Warren Buffett’s Berkshire Hathaway Inc on Tuesday said it has more than doubled its investment in generic drugmaker Teva Pharmaceutical Industries Ltd, and confirmed it has become Apple Inc’s second-largest shareholder.
Berkshire also shed an investment dating to the mid-1970s that reflected Buffett’s longstanding love for newspapers, selling its stake in Graham Holdings Co, the former publisher of the Washington Post.
The changes were disclosed in a regulatory filing detailing Berkshire’s U.S.-listed stock holdings as of March 31.
Berkshire owned about $173 billion (£128 billion) of equities, as well as dozens of businesses in the railroad, insurance, energy, chemical, food and retail and other sectors.
Berkshire said it owned about 40.5 million Teva American depositary receipts (ADRs) worth about $693 million as of that date, up from 18.9 million ADRs three months earlier.
Teva’s share price rose 5.1 percent in after-hours trading on Tuesday. Stocks often rise in price when Berkshire reveals new or increased stakes.
Larger stock investments are normally made by Buffett, while smaller bets come from his investment managers Todd Combs and Ted Weschler. The filing does not say who bought which stocks.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.